Skip to main content
Study launched by Medtronic to create OIRD risk assessment scoring tool

A 1,650-patient study was launched by Medtronic to evaluate the effect of using capnography and pulse oximetry in opioid-induced respiratory depression. The study will use 48-hour continuous pulse oximetry and capnography monitoring with the company's Capnostream device to develop an OIRD risk assessment scoring tool for use in patients receiving opioids for pain.

Full Story: